Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey

Huang, Hui-Yao; Shi, Ju-Fang; Guo, Lan-Wei; Bai, Ya-Na; Liao, Xian-Zhen; Liu, Guo-Xiang; Mao, A-Yan; Ren, Jian-Song; Sun, Xiao-Jie; Zhu, Xin-Yu; Wang, Le; Song, Bing-Bing; Du, Ling-Bin; Zhu, Lin; Gong, Ji-Yong; Zhou, Qi; Liu, Yu-Qin; Cao, Rong; Mai, Ling; Lan, Li; Sun, Xiao-Hua; Ren, Ying; Zhou, Jin-Yi; Wang, Yuan-Zheng; Qi, Xiao; Lou, Pei-An; Shi, Dian; Li, Ni; Zhang, Kai; He, Jie; Dai, Min

doi:10.1186/s40880-017-0209-4

Table 3 Univariate analysis of overall expenditure for diagnosis and treatment of 2356 patients with colorectal cancer

From: Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey

Variable	Expenditure (CNY)			Statistics^a	P ^a
Variable	Medical	Non-medical	Overall	Statistics^a	P ^a
Total	61,829	5579	67,408	–	–
Hospital type
General	52,392	4893	57,285	−4.46	<0.001
Specialized	65,786	5866	71,652
Age at diagnosis (years)
<45	65,887	6122	72,009	2.90	0.034
45–54	66,303	6049	72,352
55–64	59,416	5328	64,744
≥65	58,840	5198	64,038
Sex
Men	62,526	5751	68,277	1.34	0.181
Women	60,903	5350	66,253
Education
Primary school or below	57,354	4883	62,237	8.36	<0.001
Junior high school	58,898	5191	64,089
Senior high school	65,095	5805	70,900
Undergraduate or higher	76,132	8250	84,382
Occupation
Farmer	57,796	4973	62,769	8.19	<0.001
Enterprise or company employee/worker	63,563	5859	69,422
Self-employee or unemployee	54,449	4640	59,089
Retiree	70,629	7835	78,464
Public sector employee	72,707	5628	78,335
Others	58,197	6579	64,776
Healthcare insurance type
Urban employee basic medical insurance	66,458	6289	72,747	3.17	0.007
Urban resident basic medical insurance	60,118	4861	64,979
New rural cooperative medical scheme	58,046	5062	63,108
Commercial insurance	61,233	2958	64,191
Self-paid	53,914	5855	59,769
Others	78,293	13,023	91,316
Previous-year household income (CNY)
<20,000	53,581	4570	58,151	5.75	<0.001
20,000–39,999	61,461	5193	66,654
40,000–69,999	62,972	5586	68,558
≥70,000	65,371	6188	71,559
Pathologic type
Adenocarcinoma	62,759	5636	68,395	3.35	<0.001
Others	53,279	4501	57,780
Therapeutic regimen
Surgery	51,759	3812	55,571	14.04	<0.001
Chemotherapy	68,749	6818	75,567
Surgery and postoperative chemotherapy	63,068	5702	68,770
Symptomatic treatment	55,970	5237	61,207
Concurrent chemoradiotherapy	114,491	12,944	127,435
Radiotherapy	88,857	7989	96,846
Neoadjuvant chemotherapy and surgery	71,557	9682	81,239

CNY Chinese Yuan
^aTwo-sample Student’s t test after logarithm transition was used for binary classification variables, including hospital type, sex, and pathologic type; analysis of variance test after logarithm transition was used for other multiple categorical variables, including age at diagnosis, education, occupation, insurance type, household income, and therapeutic regimen

Back to article page

ISSN: 2523-3548

Contact us

General enquiries: info@biomedcentral.com

Cancer Communications

Contact us